Stay updated on Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial page.

Latest updates to the Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new Locations section appears with Zhejiang (Hangzhou, China) and the page revision updates to v3.3.3; the previous Zhejiang Locations entry and HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page shows a minor revision update from v3.2.0 to v3.3.2 without changes to the study content or parameters. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedRemoved the government funding/operating status notice from the page; no trial data, eligibility criteria, or study results were changed.SummaryDifference0.4%

- Check60 days agoChange DetectedNo significant changes detected in core study information (title, conditions, eligibility criteria, interventions, or outcomes). Any differences appear to be minor UI or formatting adjustments.SummaryDifference0.5%

- Check89 days agoChange DetectedCore content updated with a government-funding status notice and an OS update from v3.1.0 to v3.2.0; older version tag removed.SummaryDifference4%

- Check96 days agoChange DetectedUpgrade from v3.0.2 to v3.1.0 with added identifier and email; no changes to core content, pricing, or availability.SummaryDifference0.1%

Stay in the know with updates to Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial page.